EN DE
STOCK COMPARISON

Shandong Bailong Chuangyuan Bio-Tech Co. vs Nestle India: Fair Value & Quality

Both stocks run through our valuation models. Here is how Shandong Bailong Chuangyuan Bio-Tech Co. (605016) and Nestle India (NESTLEIND) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Shandong Bailong Chuangyuan Bio-Tech Co. as the less overvalued of the two: Shandong Bailong Chuangyuan Bio-Tech Co. trades at ¥21.33 versus a fair value of ¥14.96 (-30%), while Nestle India trades at ₹1,540 versus ₹362 (-76%).
Shandong Bailong Chuangyuan Bio-Tech Co.
605016.SHG · CNY · Consumer Staples
-30%
upside to fair value
overvalued
Price¥21.33
Fair Value¥14.96
Quality48/100
Nestle India
NESTLEIND.NSE · INR · Consumer Staples
-76%
upside to fair value
overvalued
Price₹1,540
Fair Value₹362
Quality72/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Shandong Bailong Chuangyuan Bio-Tech Co.Nestle India
Valuation
27.4×P/E (TTM)78.9×
7.27×P/S (TTM)11.91×
5.40×P/B
17.6×EV/EBITDA53.1×
1.1%Dividend yield0.8%
¥0.27Dividend per share₹12.00
Profitability
28%Net margin15%
36%Operating margin23%
21%Return on equity76%
12%Return on assets23%
Growth
25%Revenue growth (YoY)23%
24.1%Avg. growth/yr (3Y)11.3%
22.5%Avg. growth/yr (5Y)11.7%
Balance & size
0.04×Debt / equity0.00×
$2BMarket cap$29B
expensiveGrowth qualityhealthy

Shandong Bailong Chuangyuan Bio-Tech Co. leads: 9 to 3 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Shandong Bailong Chuangyuan Bio-Tech Co.of which business quality 47 · market factors 46 Nestle Indiaof which business quality 73 · market factors 78
ProfitabilityMargins and returns on capital today
67
93
Quality GrowthAre margins and returns improving?
79
50
CashflowEarnings quality: real cash, not paper profit
11
75
Fin. StrengthBalance sheet, leverage, solvency risk
93
76
InvestmentDisciplined investing over empire-building
14
42
Low VolatilityCalm price path (market factor)
70
93
MomentumPrice trend over the last 3–12 months (market factor)
39
62
52W MomentumDistance to the 52-week high (market factor)
30
88
Net IssuanceBuybacks instead of dilution
0
82

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Shandong Bailong Chuangyuan Bio-Tech Co.

DCF Models¥15.51
Earnings-Based¥18.02
Dividend Discount¥3.89
Multiples¥16.44
Asset-Based¥3.13
Economic Profit¥12.67
Growth Earnings¥24.46

15 of 17 models see the stock below the current price.

Nestle India

DCF Models₹451
Earnings-Based₹208
Dividend Discount₹229
Multiples₹278
Asset-Based₹17.92
Growth DCF₹402
Economic Profit₹198
Growth Earnings₹324

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Shandong Bailong Chuangyuan Bio-Tech Co.
Bear ¥11.36Fair Value ¥14.96Bull ¥19.92
¥21.33 = current price (white tick)
Nestle India
Bear ₹273Fair Value ₹362Bull ₹452
₹1,540 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Shandong Bailong Chuangyuan Bio-Tech Co. · Consumer Staples

Quality score48 · below median
Fair value upside-30% · below median

Nestle India · Consumer Staples

Quality score72 · Top 25%
Fair value upside-76% · bottom 25%

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Shandong Bailong Chuangyuan Bio-Tech Co. as the less overvalued of the two: Shandong Bailong Chuangyuan Bio-Tech Co. trades at ¥21.33 versus a fair value of ¥14.96 (-30%), while Nestle India trades at ₹1,540 versus ₹362 (-76%).

Nestle India has the higher quality score (72/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.